These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 15114263)
1. Serum cathepsin B activity during regression of Morris hepatoma 5123 D. Fedorowski A; Steciwko A; Rabczyński J Med Sci Monit; 2004 May; 10(5):BR144-50. PubMed ID: 15114263 [TBL] [Abstract][Full Text] [Related]
2. Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progression. Miyake H; Hara I; Eto H Anticancer Res; 2004; 24(4):2573-7. PubMed ID: 15330217 [TBL] [Abstract][Full Text] [Related]
3. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage. Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972 [TBL] [Abstract][Full Text] [Related]
4. [Significance of cathepsin B and D in physiologic and pathologic processes]. Olszewska D; Drewa T; Makarewicz R; Drewa J; Woźniak A; Maciak R Pol Merkur Lekarski; 2001 Jan; 10(55):65-70. PubMed ID: 11320558 [TBL] [Abstract][Full Text] [Related]
5. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo. Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180 [TBL] [Abstract][Full Text] [Related]
6. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents. Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414 [TBL] [Abstract][Full Text] [Related]
7. Low-frequency electromagnetic stimulation may lead to regression of Morris hepatoma in buffalo rats. Fedorowski A; Steciwko A; Rabczynski J J Altern Complement Med; 2004 Apr; 10(2):251-60. PubMed ID: 15165406 [TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Lakka SS; Gondi CS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Rao JS Oncogene; 2004 Jun; 23(27):4681-9. PubMed ID: 15122332 [TBL] [Abstract][Full Text] [Related]
10. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D. Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041 [TBL] [Abstract][Full Text] [Related]
11. Actin content and actin polymerization in hepatoma Morris 5123 tumor bearing rats after treatment with cysteine protease inhibitor and vitamin E. Sebzda T; Saleh Y; Malicka-Blaszkiewicz M; Nowak D; Siewinski M; Ziolkowski P; Kopec W J Exp Ther Oncol; 2005; 5(1):23-9. PubMed ID: 16416598 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival. Cordes C; Bartling B; Simm A; Afar D; Lautenschläger C; Hansen G; Silber RE; Burdach S; Hofmann HS Lung Cancer; 2009 Apr; 64(1):79-85. PubMed ID: 18760860 [TBL] [Abstract][Full Text] [Related]
13. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma]. Song Y; Shen K; He CX Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518 [TBL] [Abstract][Full Text] [Related]
14. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Vasiljeva O; Papazoglou A; Krüger A; Brodoefel H; Korovin M; Deussing J; Augustin N; Nielsen BS; Almholt K; Bogyo M; Peters C; Reinheckel T Cancer Res; 2006 May; 66(10):5242-50. PubMed ID: 16707449 [TBL] [Abstract][Full Text] [Related]
15. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245 [TBL] [Abstract][Full Text] [Related]
16. Cathepsins B and D activity and activity ratios in normal ovaries, benign ovarian neoplasms, and epithelial ovarian cancer. Downs LS; Lima PH; Bliss RL; Blomquist CH J Soc Gynecol Investig; 2005 Oct; 12(7):539-44. PubMed ID: 16202931 [TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide accelerates caspase-independent but cathepsin B-dependent death of human lung epithelial cells. Tang PS; Tsang ME; Lodyga M; Bai XH; Miller A; Han B; Liu M J Cell Physiol; 2006 Nov; 209(2):457-67. PubMed ID: 16894574 [TBL] [Abstract][Full Text] [Related]
18. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications. Tumminello FM; Flandina C; Crescimanno M; Leto G Biomed Pharmacother; 2008 Feb; 62(2):130-5. PubMed ID: 17728092 [TBL] [Abstract][Full Text] [Related]
19. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers. Herszényi L; István G; Cardin R; De Paoli M; Plebani M; Tulassay Z; Farinati F Eur J Cancer Prev; 2008 Oct; 17(5):438-45. PubMed ID: 18714186 [TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression. Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]